Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| DMC Biotechnologies | 2021 | Series B | $39.0M | Boulder |
| eGlint | 2021 | Seed | $2.4M | San Diego |
| BIOMILQ | 2021 | Series A | $21.0M | Durham |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | DMC Biotechnologies | Series B | $39.0M | Boulder, United States |
| 127 | eGlint | Seed | $2.4M | San Diego, United States |
| 128 | BIOMILQ | Series A | $21.0M | Durham, United States |
DMC Biotechnologies produces bio-based chemicals using fermentation.
Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.
Unlocking human potential with breakthrough mammary biotechnology.
Breakthrough Energy Ventures has invested in 128 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Breakthrough Energy Ventures's top investment sectors include Biotechnology, Food and Beverage, Chemical, Commercial, Manufacturing. The firm invests across 10 different industry categories.
Among tracked funding rounds, DMC Biotechnologies received $39.0M in a Series B round. Breakthrough Energy Ventures's total known invested capital is $3.4B.
Breakthrough Energy Ventures's average investment size is $33.5M across its portfolio of 128 companies.
Recent Breakthrough Energy Ventures portfolio additions include DMC Biotechnologies, eGlint, BIOMILQ. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors